Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tumours

A Study Evaluating The Clinical Utility Of The Health-Related Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tumours QUALINETS Study

The purpose of this study is to evaluate the utility of the QLQ-GINET21 in making clinical and therapeutic decisions.

Inclusion Criteria:

• Patient with a diagnosis of gastrointestinal endocrine tumour.
• Patient able to read and understand the study questionnaires.
• Patient who has given informed consent in writing to take part in the study.

Exclusion Criteria:

• Patient who is taking part in another clinical study during the study.
• Patients with another serious malignancy.
• Patients unable to meet the requirements of the protocol (non-compliant patients or those unfit to answer the questionnaires).